Package 71335-1378-0

Brand: buprenorphine and naloxone

Generic: buprenorphine and naloxone
NDC Package

Package Facts

Identity

Package NDC 71335-1378-0
Digits Only 7133513780
Product NDC 71335-1378
Description

42 TABLET in 1 BOTTLE (71335-1378-0)

Marketing

Marketing Status
Marketed Since 2024-05-20
Brand buprenorphine and naloxone
Generic buprenorphine and naloxone
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBLINGUAL"], "spl_id": "154fc76d-ff38-473b-aaa5-017237455b85", "openfda": {"nui": ["N0000175689", "N0000175685", "N0000175691", "N0000000154"], "unii": ["40D3SCR4GZ", "36B82AMQ7N"], "rxcui": ["351267"], "spl_set_id": ["2063d5bf-b3bc-4e73-9046-7e994446ab50"], "pharm_class_epc": ["Partial Opioid Agonist [EPC]", "Opioid Antagonist [EPC]"], "pharm_class_moa": ["Partial Opioid Agonists [MoA]", "Opioid Antagonists [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "42 TABLET in 1 BOTTLE (71335-1378-0)", "package_ndc": "71335-1378-0", "marketing_start_date": "20240520"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-1378-1)", "package_ndc": "71335-1378-1", "marketing_start_date": "20191025"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-1378-2)", "package_ndc": "71335-1378-2", "marketing_start_date": "20240520"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-1378-3)", "package_ndc": "71335-1378-3", "marketing_start_date": "20240520"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (71335-1378-4)", "package_ndc": "71335-1378-4", "marketing_start_date": "20240520"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (71335-1378-5)", "package_ndc": "71335-1378-5", "marketing_start_date": "20240520"}, {"sample": false, "description": "28 TABLET in 1 BOTTLE (71335-1378-6)", "package_ndc": "71335-1378-6", "marketing_start_date": "20240520"}, {"sample": false, "description": "6 TABLET in 1 BOTTLE (71335-1378-7)", "package_ndc": "71335-1378-7", "marketing_start_date": "20240520"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-1378-8)", "package_ndc": "71335-1378-8", "marketing_start_date": "20240520"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (71335-1378-9)", "package_ndc": "71335-1378-9", "marketing_start_date": "20240520"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "71335-1378_154fc76d-ff38-473b-aaa5-017237455b85", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "71335-1378", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE", "strength": "8 mg/1"}, {"name": "NALOXONE", "strength": "2 mg/1"}], "application_number": "ANDA205022", "marketing_category": "ANDA", "marketing_start_date": "20160919", "listing_expiration_date": "20261231"}